The Medical Products Agency in Sweden has published a summary of safety information collected during the national swine 'flu vaccination programme. Sweden is using Pandemrix® in their vaccination programme.
The information is helpfully presented in English and summarises the adverse drug reaction reports that have been collated during the vaccination programme. According to this report over 2 million doses of the vaccine have been distributed in Sweden.
The experience in Sweden is similar to the picture in the UK. Most of the reported events are mild and expected. They include injection site symptoms like soreness and reddening of the skin or systemic reactions like fever, body aches and malaise.
Action: Clinicians may find this additional source of safety monitoring information useful.
|« MeReC Extra 42||Swine flu updates »|